Article ID Journal Published Year Pages File Type
9643701 Journal of the American Academy of Child & Adolescent Psychiatry 2005 6 Pages PDF
Abstract
The results of the current open-label study suggest the effectiveness of reboxetine in the treatment of ADHD in methylphenidate-resistant children and adolescents. Double-blind, placebo-, and active comparator-controlled studies are indicated to rigorously test the efficacy of reboxetine in ADHD.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Perinatology, Pediatrics and Child Health
Preview
Six-Week Open-Label Reboxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Authors
, , , , , ,